News & Events

Events

WCBP

Jan 23-25
Washington, DC

OTx Xchange

Feb 28
Manchester Grand Hyatt San Diego, CA

AACR

April 5-10
San Diego, CA

BEBPA HCP

May 14-16
College Park, MD

ADLM

July 30-Aug 1
Chicago, IL

BPS

Aug 19-22
Boston, MA

OTS

Oct 6-9
Montreal, Quebec, Canada

SfN

Oct 5-9
Chicago, IL

MEDICA

Nov 11-14
Messe Dusseldorf Dusseldorf, Germany

News

FEBRUARY 25, 2025
Innovative Research to Advance Oligonucleotide Therapeutics now published in the Journal of Nucleic Acid Therapeutics
Our recently published manuscript reviews the current landscape and key hurdles faced in ONTs and offers antibody-based assays as an othogonal approach for localization and quantification of ONTs throughout drug development.
FEBRUARY 3, 2025
Rockland Launches AccuSignal™ E. coli ELISA Kit for Precise Detection of HCPs in Biologic Manufacturing
The AccuSignal E. coli ELISA Kit is designed to detect E. coli Host Cell Proteins (HCPs), including from strains such as B and K-12, to ensure bioprocess consistency and safety of therapeutic products.
OCTOBER 25, 2024
Abzyme Therapeutics' pH-Dependent Anti-CD3 Antibody Secures Key Patent
Abzyme Therapeutics LLC, a Rockland-affiliated biotechnology company, has reached a significant milestone in its pursuit to develop innovative antibody-based therapies.
AUGUST 22, 2024
The Jackson Laboratory Expands Partnership with Rockland and antibodies-online to Exclusively Offer Highly Characterized FcRn Antibodies for the Assessment of Therapeutic Drugs
The Jackson Laboratory Expands Partnership with Rockland and antibodies-online to Exclusively Offer Highly Characterized FcRn Antibodies for the Assessment of Therapeutic Drugs.
APRIL 16, 2024
Rockland, antibodies-online, and The Jackson Laboratory Partner to Exclusively Offer Innovative Genome Editing Tools to Researchers Worldwide
The Jackson Laboratory partners with Rockland and antibodies-online to provide genomic tools for global immuno-oncology research, diagnostics, and therapeutics development.
JANUARY 11, 2024
Rockland Launches Impurity Detection Kit for Accurate Measurement of Nuclease Across a Spectrum of Therapeutic Manufacturing Methods
The AccuSignal Nuclease ELISA Kit is designed to detect endonuclease to evaluate manufacturing processes for biological therapeutics, gene therapy vectors, vaccine preparations, and more.
OCTOBER 17, 2023
Rockland Launches Novel Analytical Tools to Assess Drug Delivery Revolutionizing Oligonucleotide Therapeutic Development
The first and only panel of specialty reagents designed to detect PS modifications independent of sequence, format, or location, streamlining candidate triage for unparalleled cost and time savings in early-stage non-clinical and pre-clinical discovery assessment of...
FEBRUARY 1, 2023
Rockland Launches Early Access Program for ModDetect™ Anti-PS Panel
Rockland, a pioneer in life science solutions, is excited to announce the initiation of the Early Access Program for its ModDetect Anti-PS Monoclonal Antibody Panel.
Load More